Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line

References

• Abraxane®. 2005. Abraxane Package Insert. Available from: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4235B2-01-01AbraxisBioscience-background.pdf.
   Google Scholar
• Aiping Z, Jianhong L, Wenhul Y. 2006. Effective loading and controlled release of camptothecin by O-carboxymethylchitosan aggregates. Carbohydr Polym. 63:89–96.
   Web of Science ®Google Scholar
• Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Jayakumar R. 2012. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J Biomater Sci Polym Ed. 23:1381–1400.
   PubMed Web of Science ®Google Scholar
• Anitha A, Rani VVD, Krishna R, Sreeja V, Selvamurugan N, Nair SV, Tamura H, Jayakumar R. 2009. Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N, O-carboxymethyl chitosan nanoparticles. Carbohydr Polym. 78:672–667.
   Web of Science ®Google Scholar
• Carter DC, Ho JX. 1994. Structure of serum-albumin. Adv Protein Chem. 45:153–203.
   PubMedGoogle Scholar
• Cetin M, Atila A, Kadioglu Y. 2010. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech. 11:1250–1256.
   PubMed Web of Science ®Google Scholar
• Chen J, Davis SS. 2002. The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres. J Microencapsul. 19:191–201.
   PubMed Web of Science ®Google Scholar
• Cohen S, Pellach M, Kam Y, Grinberg I, Corem-Salkmon E, Rubinstein A, Margel S. 2013. Synthesis and characterization of near IR fluorescent albumin nanoparticles for optical detection of colon cancer. Mater Sci Eng C Mater Biol Appl. 33:923–931.
   PubMed Web of Science ®Google Scholar
• Das S, Banerjee R, Bellare J. 2005. Aspirin loaded albumin nanoparticles by coacervation: implications in drug delivery. Trends Biomater Artif Organs. 18:203–212.
   Google Scholar
• Dumont VC, Mansur AAP, Carvalho SM, Borsagli FGLM, Pereira MM, Mansur HS. 2016. Chitosan and carboxymethyl-chitosan capping ligands: effects on the nucleation and growth of hydroxyapatite nanoparticles for producing biocomposite membranes. Mater Sci Eng C. 59:265–277.
   PubMed Web of Science ®Google Scholar
• Dustin LC, Harirforoosh S. 2014. Design and optimization of PLGA-based diclofenac loaded nanoparticles. PLoS One. 9:e87326.
   PubMed Web of Science ®Google Scholar
• Erdal E, Kavaz D, Sam M, Demirbilek M, Demirbilek ME, Saglam N, Denkbas EB. 2012. Preparation and characterization of magnetically responsive bacterial polyester based nanospheres for cancer therapy. J Biomed Nanotechnol. 8:1–9.
   PubMed Web of Science ®Google Scholar
• Ernest HR. N, O-carboxymethyl chitosan and preparative method therefore, United States Patents. US4619995, Oct 28, 1986.
   Google Scholar
• Errico C, Bartoli C, Chiellini F, Chiellini E. 2009. Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery. J Biomed Biotech. 2009:571702.
   PubMedGoogle Scholar
• Gulsu A, Ayhan H, Ayhan F. 2012. Preparation and characterization of ketoprofen loaded albumin microspheres. Turk J Biochem. 37:120–128.
   Web of Science ®Google Scholar
• Ha W, Wu H, Wang XL, Peng SL, Ding LS, Zhang S, Li BJ. 2011. Self-aggregates of cholesterol-modified carboxymethyl konjac glucomannan conjugate: preparation, characterization, and preliminary assessment as a carrier of etoposide. Carbohydr Polym. 86:513–519.
   Web of Science ®Google Scholar
• Hattori Y, Shi L, Ding W, Koga K, Kawano K, Hakoshima M, Maitani Y. 2009. Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors. J Control Release. 136:30–37.
   PubMed Web of Science ®Google Scholar
• Jayakumar R, Prabaharan M, Nair SV, Tokura S, Tamura H, Selvamurugan N. 2010. Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications. Prog Mater Sci. 55:675–709.
   Web of Science ®Google Scholar
• Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. 2000. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm. 50:147–160.
   PubMed Web of Science ®Google Scholar
• Kavaz D, Odabas S, Guven E, Demirbilek M, Denkbas EB. 2010. Bleomycin loaded magnetic chitosan nanoparticles as multifunctional nanocarriers. J Bioact Compat Polym. 25:305–318.
   Web of Science ®Google Scholar
• Kean T, Thanou M. 2010. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 62:3–11.
   PubMed Web of Science ®Google Scholar
• Keck CM, Muller RH. 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 62:3–16.
   PubMed Web of Science ®Google Scholar
• Kilicay E, Demirbilek M, Turk M, Guven E, Hazer B, Denkbas EB. 2011. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci. 44:310–320.
   PubMed Web of Science ®Google Scholar
• Kim DG, Jeong YI, Choi C, Roh SH, Kang SK, Jang MK, Nah JW. 2006. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles. Int J Pharm. 319:130–138.
   PubMed Web of Science ®Google Scholar
• Kufleitner J, Worek F, Kreuter J. 2010. Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation. J Microencapsul. 27:594–601.
   PubMed Web of Science ®Google Scholar
• Kumar MNVR, Bakowsky U, Lehr CM. 2004. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 25:1771–1777.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. 2001. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf A: Physicochem Eng Aspects. 182:123–130.
   Web of Science ®Google Scholar
• Langer K, Anhorn MG, Steinhauser I, Dreis S, Celebi D, Schrickel N, Faust S, Vogel V. 2008. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int J Pharm. 347:109–113.
   PubMed Web of Science ®Google Scholar
• Leroux JC, Allemann E, Jaeghere FD, Doelker E, Gurny R. 1996. Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. J Control Release. 39:339–350.
   Web of Science ®Google Scholar
• Lin W, Coombes A, Davies M, Davis S, Illum L. 1993. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target. 1:237–243.
   PubMed Web of Science ®Google Scholar
• Lorenza MR, Holzapfel V, Musyanovych A, Nothelfer K, Walther P, Frank H, et al. 2006. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials. 27:2820–2828.
   PubMed Web of Science ®Google Scholar
• Medeiros SF, Santos AM, Fessi H, Elaissari A. 2010. Synthesis of biocompatible and thermally sensitive poly(N-vinylcaprolactam) nanogels via inverse miniemulsion polymerization: effect of the surfactant concentration. J Polym Sci Pol Chem. 48:3932–3941.
   Web of Science ®Google Scholar
• Merodio M, Arnedo A, Renedo MJ, Irache JM. 2001. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur J Pharm Sci. 12:251–259.
   PubMed Web of Science ®Google Scholar
• Mo Y, Barnett ME, Takemoto D, Davidson H, Kompella UB. 2007. Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis. 13:746–757.
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3876.
   PubMed Web of Science ®Google Scholar
• Muzzarelli RAA. 1988. Carboxymethylated chitin and chitosans. Carbohydr Polym. 8:1–21.
   Web of Science ®Google Scholar
• Nanda R, Sasmal A, Nayak PL. 2011. Preparation and characterization of chitosan-polylactide composites blended with Cloisite 30B for control release of the anticancer drug paclitaxel. Carbohydr Polym. 83:988–994.
   Web of Science ®Google Scholar
• Onyuksela H, Mohantya PS, Rubinstein I. 2009. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer. Int J Pharm. 365:157–161.
   PubMed Web of Science ®Google Scholar
• Rello-Varona S, Gamez A, Moreno V, Stockert JC, Cristobal J, Pacheco M, et al. 2006. Metaphase arrest and cell death induced by etoposide on HeLa cells. Int J Biochem Cell Biol. 38:2183–2195.
   PubMed Web of Science ®Google Scholar
• Saberi AH, Fang Y, McClements DJ. 2013. Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification. J Colloid Interface Sci. 391:95–102.
   PubMed Web of Science ®Google Scholar
• Sanjeev KP, Ghosh S, Maiti P, Haldar C. 2015. Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer. Int J Biol Macromol. 72:309–319.
   PubMed Web of Science ®Google Scholar
• Schlicher EJAM, Postma NS, Zuidema J, Talsma H, Hennink WE. 1997. Preparation and characterisation of poly (D, L-lactic-co-glycolic acid) microspheres containing desferrioxamine. Int J Pharm. 153:235–245.
   Web of Science ®Google Scholar
• Schork FJ, Luo YW, Smulders W, Russum JP, Butte A, Fontenot K. 2005. Miniemulsion polymerization. Adv Polym Sci. 175:129–255.
   Web of Science ®Google Scholar
• Senear DF, Teller DC. 1981. Thermodynamics of concanavalin A dimer-tetramer self association: sedimentation equilibrium studies. Biochemistry. 20:3076–3083.
   PubMed Web of Science ®Google Scholar
• Tiegs G, Hentschel J, Wendel AAT. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 90:196–203.
   PubMed Web of Science ®Google Scholar
• Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. 2008. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv. 5:155–174.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisar P, Cinatl J, Kreuter J. 2011. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int J Pharm. 406:128–134.
   PubMed Web of Science ®Google Scholar
• Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. 2003. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials. 24:1001–1011.
   PubMed Web of Science ®Google Scholar
• Yang M, Dutta C, Tiwari A. 2015. Disulfide-bond scrambling promotes amorphous aggregates in lysozyme and bovine serum albumin. J Phys Chem B. 119:3969–3981.
   PubMed Web of Science ®Google Scholar
• Yong H, Jingwei X, Yen WT, Chi-Hwa W. 2007. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release. 118:7–17.
   PubMed Web of Science ®Google Scholar
• Yun Lu X, Zhang Y, Wang L. 2010. Preparation and in vitro drug-release behavior of 5-fluorouracil-loaded poly(hydroxybutyrate-co-hydroxyhexanoate) nanoparticles and microparticles. J Appl Polym Sci. 116:2944–2950.
   Web of Science ®Google Scholar
• Zauner W, Farrow NA, Hainess AMR. 2001. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control. 71:39–51.
   Web of Science ®Google Scholar
• Zhang N, Xia Y, Guo X, Wang P, Yan S, Lu C, Cao D, Zhang Z. 2014. Preparation, characterization, and in vitro targeted delivery of folate-conjugated 2-methoxyestradiol-loaded bovine serum albumin nanoparticles. J Nanopart Res. 16:2390.
   Web of Science ®Google Scholar
• Zinn M, Witholt B, Egli T. 2001. Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Adv Drug Deliv Rev. 53:5–21.
   PubMed Web of Science ®Google Scholar